1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. APELLIS PHARMACEUTICALS INC
Apellis Pharmaceuticals Inc XNAS: APLS

Apellis Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement s...

Read More
28.12 0.32 (1.15%)
32.95% Fall from 52W High
1.0M
XNAS Volume

XNAS 04 Sep, 2025 2:43 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Apellis Pharmaceuticals Inc is on 09 Sep 2025 for the purpose of Baird Global Healthcare Conference See details
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Expensive Valuation
10.8 / 100
Momentum Score
Technically Neutral
51.1 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
39
1Yr Price target upside is 37%
18 analysts

17

S

10

W

1

O

2

T

SWOT Analysis

Apellis Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..